mRNA |
AZD-2281 |
FIMM |
pan-cancer |
AAC |
0.13 |
0.4 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |